Summary
The success rate of cardiopulmonary resuscitation in patients with cardiac arrest due to ventricular fibrillation is predominantly determined by early de-fibrillation. Biphasic shocks appear superior as compared to standard monophasic shocks. Antiarrhythmic drug treatment only plays a role in cases of refractory ventricular fibrillation despite repetitive defibrillation and application of epinephrine. Amiodarone facilitates the restitution of a stable rhythm and spontaneous circulation; however, no long-term prognostic improvement has been shown. There are no prospective studies showing any benefit for the use of lidocaine during cardiac arrest. Under normal conditions, magnesium does not affect prognosis in patients with cardiac arrest and is only recommended in situations with suspected magnesium deficiency or torsades de pointes.
Zusammenfassung
Entscheidend für den Erfolg einer Reanimation bei Kammerflimmern ist die möglichst frühzeitige Defibrillation. Erste Hinweise sprechen dafür, dass hierbei biphasische Schocks den monophasischen Schocks überlegen sind. Einer zusätzlichen antiarrhythmischen Pharmakotherapie im Rahmen einer Reanimation kommt erst für den Fall von persistierendem Kammerflimmern nach mehreren Schocks und Gabe von Adrenalin eine Bedeutung zu. Amiodaron begünstigt in diesem Fall die Restitution eines stabilen Rhythmus und Wiederherstellung eines Kreislaufes. Eine langfristige Prognoseverbesserung durch Amiodaron ist allerdings nicht nachgewiesen. Für Lidocain wurde bisher kein eindeutiger Nutzen im Rahmen einer Reanimation gezeigt, da prospektive Studien zur Prognose fehlen. Die Gabe von Magnesium hat unter normalen Umständen keinen Einfluss auf die Prognose und wird nur bei vermutetem Magnesiummangel oder Torsade de Pointes Tachykardien empfohlen.
Preview
Unable to display preview. Download preview PDF.
Literatur
Adgey AAJ, Johnston PW (1998) Approaches to modern management of cardiac arrest. Heart 80: 397–401
Ballew KA, Philbrick JT (2000) Amio-darone in out-of-hospital cardiac arrest. N Engl J Med 342: 216–217
Bardy GH, Marchlinski FE, Sharma AD, Worley SJ, Luceri RM, Yee R, Halperin BD, Fellows CL, Ahern TS, Chilson DA, Packer DL, Wilber DJ, Mattioni TA, Reddy R, Kronmal RA, Lazzara R (1996) Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic investigators. Circulation 94: 2507–2514
Bayes de Luna A, Coumel P, Leclercq JF (1989) Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117: 151–159
Becker LB, Ostrander MP, Barrett J, Kondos GT (1991) Outcome of CPR in a large metropolitan area — where are the survivors? Ann Emerg Med 20: 355–361
Behrens S, Li C, Kirchhof P, Fabritz FL, Franz MR (1996) Reduced ar-rhythmogenicity of biphasic versus monophasic T wave shocks. Implications for defibrillation efficacy. Circulation 94: 1974–1980
Borer JS, Harrison LA, Kent KM, Levy R, Goldstein RE, Epstein SE (1976) Beneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction. Am J Cardiol 37: 860–863
Chen PS, Shibata N, Dixon EG, Wolf PD, Danieley ND, Sweeney MB, Smith WM, Ideker RE (1986) Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. J Clin Invest 77: 810–823
Chow MS, Kluger J, Lawrence R, Fieldman A (1986) The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Biol Med 182: 63–67
Craddock L, Miller B, Clifton G, Krumbach B, Pluss W (1991) Resuscitation from prolonged cardiac arrest with high-dose intravenous magnesium sulfate. J Emerg Med 9: 469–476
Cummins RO (1989) From concept to standard-of-care? Review of the clinical experience with automated external defibrillators. Ann Emerg Med 18: 1269–1275
Cummins RO (1997) Advanced cardiac life support. Dallas, TX: American Heart Association, 1–17
Dahl CF, Ewy GA, Warner ED, Thomas ED (1974) Myocardial necrosis from direct current countershock: effect of paddle electrode size and time interval between discharges. Circulation 50: 956–961
Echt DS, Black JN, Barbey JT, Coxe DR, Cato E (1989) Evaluation of anti-arrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation 79: 1106–1117
Eisenberg MS, Copass MK, Hallstrom AP, Blake B, Bergner L, Short FA, Cobb LA (1980) Treatment of out-of-hospital cardiac arrests with rapid defibrillation by emergency medical technicians. N Engl J Med 302: 1379–1383
Eisenberg MS, Horwood BT, Cummins RO, Reynolds HR, Hearne TR (1990) Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med 19: 179–186
Fain ES, Sweeney MB, Franz MR (1989) Improved internal defibrillation efficacy with a biphasic waveform. Am Heart J 117: 358–364
Fatovich DM, Prentice DA, Dobb GJ (1997) Magnesium in cardiac arrest (the magic trial). Resuscitation 35: 237–341
Fletcher GF, Cantwell JD (1977) Ventricular fibrillation in a medically supervised cardiac exercise program: clinical, angiographic, and surgical correlations. JAMA 238: 2627–2629
Gallagher EJ, Lombardi G, Gennis P (1995) Effectiveness of bystander car-diopulmonary resuscitation and survival following out-of-hospitel cardiac arrest. JAMA 274: 1922–1925
Gettes LS (1992) Electrolyte abnormalities underlying lethal and ventricular arrhythmias. Circulation 85 (suppl): I170–176
Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B, for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology (2000) Practical Guidelines for clinicians who treat patients with amiodarone. Arch Intern Med 160: 1741–1748
Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care (2000) Part 4: The automated external defibrillator — key link in the chain of survival. Circulation 102 (suppl): I 60–76
Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care (2000) Part 6: Advanced cardiovascular life support. Section 2: Defibrillation. Circulation 102 (suppl): I-90–94
Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care (2000) Part 6: Advanced cardiovascular life support. Section 5: Pharmacology I: Agents for arrhythmias. Circulation 102 (suppl): I-112–128
Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care (2000) Part 6: Advanced cardiovascular life support. Section 7C: A guide to the international ACLS algorithms. Circulation 102 (suppl): I-142–157
Haskell WL (1978) Cardiovascular complications during exercise training of cardiac patients. Circulation 57: 920–924
Haynes RE, Chinn TL, Copass MK, Cobb LA (1981) Comparison of bre-tylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Am J Cardiol 48: 353–356
Herlitz J, Bahr J, Fischer M, Kuisma M, Lexow K, Thorgeirsson G (1999) Resuscitation in Europe. A tale of five European regions. Resuscitation 41: 121–131
Herlitz J, Ekström L, Wennerblom B, Axxelsson A, Bang A, Lindkvist J, Persson NG, Holmberg S (1997) Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? Resuscitation 33: 199–205
Hine LK, Laird N, Hewitt P, Chalmers TC (1989) Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 149: 2694–2698
Hossack KF, Hartwig R (1982) Cardiac arrest associated with supervised cardiac rehabilitation. J Cardiac Rehab 2: 402–408
Reseach Group IMPACT (1984) International Mexiletine and Placebo Anti-arrhythmic Coronary Trial, I: report on arrhythmia and other findings. J Am Coll Cardiol 4: 1148–1163
Kentsch M, Berkel H, Bleifeld W (1988) Intravenöse Amiodaron-Applikation bei therapierefraktärem Kammerflimmern. Intensivmedizin 25: 70–74
Kerber RE, Grayzel J, Hoyt R, Marcus M, Kennedy J (1981) Transthoracic resistance in human defibrillation: influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 63: 676–682
Kerber RE, Pandian NG, Jensen SR, Constantin L, Kieso RA, Melton J, Hunt M (1986) Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. J Am Coll Cardiol 7: 397–405
Koster RW, Dunning AJ (1985) Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospita-lization phase of acute myocardial infarction. N Engl J Med 313: 1105–1110
Kowey PR, Levine JH, Herre JM, Pacifico A, Lindsay BD, Plumb VJ, Janosik DL, Kopelman HA, Scheinman MM (1995) Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodyna-mically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 92: 3255–3263
Kowey PR, Marinchak RA, Rials SJ, Bharucha DB (1999) Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation. Am J Cardiol 84: 46R–51R
Kowey PR, Marinchak RA, Rials SJ, Filart RA (1997) Intravenous amiodarone. J Am Coll Cardiol 29: 1190–1198
Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Aalistrom AP, Murray WA, Olsufka M, Walsh T (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341: 871–878
Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP (1993) Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med 22: 1652–1658
Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes A, Woosley RL (1996) Intravenous amiodarone for recurrent sustained hypotensive ventricular ta-chyarrhythmias. J Am Coll Cardiol 27: 67–75
Lie KI, Wellens HJ, van Capelle FJ, Durrer D (1974) Lidocaine in the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. N Engl J Med 291: 1324–1326
MacMahon S, Collins R, Peto R, Koster RW, Yusuf S (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from randomized, controlled trials. JAMA 260: 1910–1916
Miller B, Craddock L, Hoffenberg S, Heinz S, Lefkowitz D, Callender ML, Battaglia C, Maines C, Masick D (1995) Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies. Resuscitation 30: 3–14
Mittal S, Ayati S, Stein KM, Knight BP, Morady F, Schwartzman D, Cavlovich D, Platia EV, Calkins H, Tchou PJ, Miller JM, Wharton JM, Sung RJ, Slotwiner DJ, Markowitz SM, Lerman BB, for the ZOLL Investigators (1999) Comparison of a rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. J Am Coll Cardiol 34: 1595–1601
Olson DA, Thompson BM, Darin JC, Milbrath MH (1984) A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 13: 807–810
Page RL, Joglar JA, Kowal RC, Zagrodzky JD, Nelson LL, Ramaswamy K, Barbera SJ, Hamdan MH, McKenas DK (2000) Use of automated external defibrillators by a US Airline. N Engl J Med 343: 1210–1216
Poole JE, White RD, Kanz KG, Hengstenberg F, Jarrard GT, Robinson JC, Santana V, McKenas DK, Rich N, Rosas S, Merritt S, Magnotto L, Gallagher JVI, Gliner BE, Jorgenson DB, Morgan CB, Dillon SM, Kronmal RA, Bardy GH (1997) Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. LIFE investigators. J Cardiovasc Electrophysiol 8: 1373–1385
Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EEI, Weaver WD (1999) 1999 update: ACC/AHA guidelines for the management of patients with acute myocar-dial infarction: executive summary and recommendations: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myo-cardial Infarction). Circulation 100: 1016–1030
Sadowski ZP, Alexander JH, Skrabucha B, Dyduszynski A, Kuch J, Nartowicz E, Swiatecka G, Kong DF, Granger CB (1999) Multicenter randomized trial and a systemic overview of lidocaine in acute myocardial infarction. Am Heart J 137: 792–798
Scheinman MM, Levine LH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, Platia E, Wilber DJ, Kowey PR (1995) Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular ta-chyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 92: 3264–3272
Schneider T, Martens PR, Paschen H, Kuisma M, Wolcke B, Gliner BE, Russell JK, Weaver WD, Bossaert L, Chamberlain D (2000) Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200-to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation 102: 1780–1787
Shibata N, Chen PS, Dixon EG, Wolf PD, Danieley ND, Smith WM, Ideker RE (1988) Epicardial activation after unsuccessful defibrillation shocks in dogs. Am J Physiol 255: H902–H909
Sirna SJ, Ferguson DW, Charbonnier F, Kerber RE (1988) Factors affecting transthoracic impedance during electrical cardioversion. Am J Cardiol 62: 1048–1052
Stults KR, Brown DD, Schug VL, Bean JA (1984) Prehospital defibrillation performed by emergency medical technicians in rural communities. N Engl J Med 310: 219–223
Swor RA, Jackson RE, Cynar M, Sadler E, Basse E, Boji B, Rivera-Rivera EJ, Maher A, Grubb W, Jacobson R, et al (1995) Bystander CPR, ventricular fibrillation, and survival in witnessed, unmonitored out-of-hospital cardiac arrest. Ann Emerg Med 25: 780–784
Thel MC, Armstrong AL, McNulty SE, Califf RM, O’Connor CM, Housestaff DIM (1997) Randomised trial of magnesium in in-hospital cardiac arrest. Lancet 350: 1272–1276
Tobey RC, Birnbaum GA, Allegra JR, Horowitz MS, Plosay Jd (1992) Successful resuscitation and neurologic recovery from refractory ventricular fibrillation after magnesium sulfate administration. Ann Emerg Med 21: 92–96
Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S (1988) Treatment of torsade de pointes with magnesium sulfate. Circulation 77: 392–397
Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG (2000) Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 343: 1206–1209
Valenzuela TD, Spaite DW, Meislin HW, Clark LL, Wright AL, Ewy GA (1992) Case and survival définitions in out-of-hospital cardiac arrest: effect on survival rate calculation. JAMA 267: 272–274
van Camp SP, Peterson RA (1986) Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA 256: 1160–1163
van Walraven C, Stiell IG, Wells GA, Hebert PC, Vandemheen K, for the OTAC Study Group (1998) Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? Ann Emerg Med 32: 544–553
Ware DL, Atkinson JB, Brooks MJ, Echt DS (1993) Ventricular defibrillation in canines with chronic infarction, and effects of lidocaine and procainamide. Pacing Clin Electrophysiol 16: 337–346
Weaver WD, Cobb LA, Copass MK, Hallstrom AP (1982) Ventricular defibrillation: a comparative trial using 175-J and 320-J shocks. N Engl J Med 307: 1101–1106
Weaver WD, Fahrenbruch CE, Johnson DD, Hallstrom AP, Cobb LA, Copass MK (1990) Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 82: 2027–2034
Winkle RA, Mead RH, Ruder MA, Gaudiani V, Buch WS, Pless B, Sweeney M, Schmidt P (1989) Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 117: 122–127
Woods KL (1991) Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 32: 3–10
Wyse DG, Kavanagh KM, Gillis AM, Mitchell LB, Duff HJ, Sheldon RS, Kieser TM, Maitland A, Flanagan P, Rothschild J et al (1993) Comparison of biphasic and monophasic shocks for defibrillation using a nonthora-cotomy system. Am J Cardiol 71: 197–202
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Behrens, S., Zabel, M. (2002). Antiarrhythmic therapy during cardiac arrest electrical defibrillation and antiarrhythmic drugs. In: Arntz, HR. (eds) Die Notfalltherapie bei akutem Kreislaufstillstand. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57511-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-57511-2_6
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1356-3
Online ISBN: 978-3-642-57511-2
eBook Packages: Springer Book Archive